Riskpilot← Back to searchSign inGet full accessSTB Stockholm AB
ABActiveOrg 5591629422Huvudfabriksgatan 6Other human health activities n.e.c. · NACE 8699Est. 20181 employees
Revenue 2025
SEK 710K
-32% vs 2024
EBITDA margin
13.2%
+306% vs 2024
Equity ratio
50.3%
Financial strength
Net profit 2025
SEK 80K
+274% vs 2024
| Revenue | SEK 710K | -32% |
| EBITDA | SEK 94K | +306% |
| Net profit | SEK 80K | +274% |
| Total assets | SEK 258K | +37% |
| Equity | SEK 130K | +162% |
| Employees | 1 | — |
Legal name
STB Stockholm AB
Org number
5591629422
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
20 juni 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Invest in Life innefattar tjänster inom hälsa, personlig träning, kost och friskvård.
Address
Huvudfabriksgatan 6
Email
invest-in-life@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 319 | 810 | 1 339 | 1 052 | 710 |
| Staff expenses | — | −632 | −1 153 | −1 033 | −504 |
| EBITDA | 10 | 91 | 50 | −46 | 94 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 10 | 91 | 50 | −46 | 94 |
| Net financials | −1 | −1 | −2 | −0 | −0 |
| Profit before tax | 10 | 91 | 48 | −46 | 94 |
| Tax | −0 | −14 | −18 | — | −13 |
| Net profit | 10 | 77 | 30 | −46 | 80 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 112 | 253 | 251 | 188 | 258 |
| Equity | 69 | 145 | 96 | 50 | 130 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 43 | 107 | 156 | 138 | 128 |
| Total debt | 43 | 107 | 156 | 138 | 128 |
EBITDA margin
13.2%
This company
15.8%
Market median
-16% vs market
20212025
Equity ratio
50.3%
This company
38.2%
Market median
+32% vs market
20212025
Return on equity
61.8%
This company
18.4%
Market median
+236% vs market
20212025
Net profit margin
11.3%
This company
8.1%
Market median
+40% vs market
20212025
Asset turnover
2.75×
This company
1.12×
Market median
+146% vs market
20212025
Debt / equity
0.99×
This company
0.62×
Market median
+60% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TL Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of STB Stockholm AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tobias Lars Emil Axelsson Bentzer | Chief Executive Officer | 0 companies |
| Anne-Charlotte Stenfelt | Deputy Board Member | 0 companies |
| Sandra Karin Bentzer | Chairman | 0 companies |